Insights

Strategic Acquisition As part of Abcam following its acquisition of MarkerGene Technologies, the company is expanding its product offerings and scientific capabilities, presenting opportunities to introduce complementary laboratory and research solutions.

Innovation Focus Recent product launches like the SimpleStep Ignite ELISA platform highlight Abcam's commitment to cutting-edge assay technologies, indicating a potential demand for advanced laboratory instrumentation and automation solutions.

Financial Landscape With annual revenues under 1 million dollars and recent funding of 6.5 million dollars, the company is positioned for growth and may be receptive to investment in scalable R&D tools and supply chain enhancements.

Leadership Transitions Frequent executive changes, including new appointments of leaders like Markus Lusser, suggest a dynamic strategic direction that offers an opening to provide executive-level solutions or consulting services to support organizational growth.

Technological Integration Utilizing a tech stack including Docker, Grafana, and cloud-based advertising tools, the company displays a modern, digital-first approach, indicating potential opportunities for advanced data analytics, cloud infrastructure, and marketing technology solutions.

Similar companies to Expedeon (now part of Abcam)

Expedeon (now part of Abcam) Tech Stack

Expedeon (now part of Abcam) uses 8 technology products and services including Google AdWords, Grafana, Docker, and more. Explore Expedeon (now part of Abcam)'s tech stack below.

  • Google AdWords
    Advertising
  • Grafana
    Analytics
  • Docker
    Containerization
  • StackAdapt
    Demand Side Platforms
  • Element UI
    Javascript Frameworks
  • JavaScript
    Programming Languages
  • Trello
    Project Management
  • PowerShell
    Security

Media & News

Expedeon (now part of Abcam)'s Email Address Formats

Expedeon (now part of Abcam) uses at least 2 format(s):
Expedeon (now part of Abcam) Email FormatsExamplePercentage
First.Last@expedeon.comJohn.Doe@expedeon.com
73%
Last@expedeon.comDoe@expedeon.com
18%
First@expedeon.comJohn@expedeon.com
9%
First.Last@abcam.comJohn.Doe@abcam.com
88%
FLast@abcam.comJDoe@abcam.com
11%
First.L@abcam.comJohn.D@abcam.com
1%

Frequently Asked Questions

Where is Expedeon (now part of Abcam)'s headquarters located?

Minus sign iconPlus sign icon
Expedeon (now part of Abcam)'s main headquarters is located at Over, England cb24 5qe United Kingdom. The company has employees across 2 continents, including EuropeNorth America.

What is Expedeon (now part of Abcam)'s phone number?

Minus sign iconPlus sign icon
You can contact Expedeon (now part of Abcam)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Expedeon (now part of Abcam)'s official website and social media links?

Minus sign iconPlus sign icon
Expedeon (now part of Abcam)'s official website is abcam.com and has social profiles on LinkedInCrunchbase.

How much revenue does Expedeon (now part of Abcam) generate?

Minus sign iconPlus sign icon
As of April 2026, Expedeon (now part of Abcam)'s annual revenue is estimated to be $3.6M.

What is Expedeon (now part of Abcam)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Expedeon (now part of Abcam)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Expedeon (now part of Abcam) have currently?

Minus sign iconPlus sign icon
As of April 2026, Expedeon (now part of Abcam) has approximately 6 employees across 2 continents, including EuropeNorth America. Key team members include Director: H. L.Account Manager: C. P.Senior Customer Services: K. F.. Explore Expedeon (now part of Abcam)'s employee directory with LeadIQ.

What industry does Expedeon (now part of Abcam) belong to?

Minus sign iconPlus sign icon
Expedeon (now part of Abcam) operates in the Biotechnology Research industry.

What technology does Expedeon (now part of Abcam) use?

Minus sign iconPlus sign icon
Expedeon (now part of Abcam)'s tech stack includes Google AdWordsGrafanaDockerStackAdaptElement UIJavaScriptTrelloPowerShell.

What is Expedeon (now part of Abcam)'s email format?

Minus sign iconPlus sign icon
Expedeon (now part of Abcam)'s email format typically follows the pattern of First.Last@expedeon.com. Find more Expedeon (now part of Abcam) email formats with LeadIQ.

How much funding has Expedeon (now part of Abcam) raised to date?

Minus sign iconPlus sign icon
As of April 2026, Expedeon (now part of Abcam) has raised $6.5M in funding. The last funding round occurred on Aug 30, 2018 for $6.5M.

Expedeon (now part of Abcam)

Biotechnology ResearchEngland, United Kingdom2-10 Employees

We are now part of Abcam and will shortly be closing this account. Follow Abcam for the latest news and information. See you there!

Section iconCompany Overview

Headquarters
Over, England cb24 5qe United Kingdom
Phone number
Website
abcam.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $6.5M

    Expedeon (now part of Abcam) has raised a total of $6.5M of funding over 2 rounds. Their latest funding round was raised on Aug 30, 2018 in the amount of $6.5M.

  • $1M

    Expedeon (now part of Abcam)'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $6.5M

    Expedeon (now part of Abcam) has raised a total of $6.5M of funding over 2 rounds. Their latest funding round was raised on Aug 30, 2018 in the amount of $6.5M.

  • $1M

    Expedeon (now part of Abcam)'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.